Brello Health advertises compounded NAD+ through a home-delivery program with clinician review. The detail that matters most for budgeting is its payment schedule: the product page shows $239 due initially and another $239 every eleven weeks, despite describing the offer as a three-month plan and promoting a $79 monthly figure.
This review uses Brello’s product page and checkout terms checked September 19, 2026. We did not enroll, order medication, or assess treatment results. The review focuses on what those public documents make clear, where the calendar needs attention, and which questions remain specific to your prescription.
Brello’s $79 headline is a multi-month offer. Budget around the stated $239 payment and eleven-week renewal, and check the current terms for your order.
Read the renewal interval before the monthly headline
The NAD+ product page presents a monthly equivalent but collects a larger payment. Its checkout terms also specify an eleven-week renewal for the NAD+ medication-only plan. Eleven weeks is shorter than three calendar months, so simply multiplying the headline by twelve can understate the cash flow of repeated renewals.
Ask Brello to show the first several charge dates in writing. Also confirm whether payment timing, shipping timing, and the expected medication supply cover the same interval. Our NAD+ cost guide explains why the number on a price card and the amount leaving your bank account can tell different stories.
Understand what is being purchased
The offer describes a provider health review, medication if approved, and injection supplies and instructions. It also advertises lifestyle resources and an online community. Those extras may affect your experience of the service, but they do not establish the effectiveness or suitability of the prescription itself.
Confirm whether you are selecting NAD+ alone or a combination program. Brello markets plans that include other medications, and their prices and eligibility requirements should be evaluated separately. You should not need to infer the contents of a medical order from the name of a lifestyle package or a photograph of several products.
Cancellation and refunds are separate questions
The product page describes a potential refund minus a $50 professional-services fee in its cancellation information. That is a reason to read the current terms carefully, not a promise that every stage of an order can be reversed. Ask exactly when clinical review and pharmacy processing occur and which charges become nonrefundable at those points.
For a recurring plan, save the cancellation confirmation and the date it takes effect. Ask how a clinician-directed stop is handled when medication has already been dispatched. We have not tested Brello’s customer support or refund process, so this review does not rate response speed or predict the outcome of an individual request.
Get the pharmacy details behind the brand
Brello describes medication supplied through a U.S. 503A partner pharmacy. The useful next step is to identify the actual dispensing facility and verify the label you would receive. The brand’s description of its pharmacy model should not be treated as FDA approval of compounded NAD+.
Ask who handles storage questions, damaged deliveries, and a label that differs from an earlier refill. If you have limited hand strength or difficulty reading small markings, raise that before ordering supplies. The label-reading guide explains which details to have the pharmacist clarify without offering a dosing schedule.
Decide what follow-up should look like
Brello’s convenience may appeal to people already comfortable with telehealth, but convenience and clinical benefit require separate assessment. Ask what outcome the clinician would monitor and how long you should wait before reviewing whether the plan makes sense. An automatic charge should not be the only reason a treatment continues.
Read our NAD+ evidence overview before relying on testimonials about energy or focus. Someone else’s reported improvement does not establish what caused it, which preparation they received, or whether the same approach is suitable for you. Persistent or changing symptoms deserve a clinical assessment beyond a product selection.
Compare payment structures, not just price cards
The GobyMeds review examines a one-month option alongside a three-month purchase. The Effecty review covers a much longer commitment behind its lowest monthly equivalent. Compare the initial cash requirement, cancellation exposure, and refill calendar before trying to decide which is more affordable.
For another reference point, see the CoreAge Rx review; CoreAge Rx is our commercial partner. Brello’s publicly stated renewal interval is the clearest reason to look beyond its headline. A written quote and a clear clinical plan are more useful than an unsupported claim that one brand works better.
Follow the source
References & further reading
- Brello Health — compounded NAD+ offer
Checked September 19, 2026. Shows a $239 upfront payment and an eleven-week renewal; the monthly headline is an equivalent.
- Brello Health — checkout terms
Checked September 19, 2026. Medication-only and combination plans have separate terms. No purchase or refund process was tested.
- FDA — compounding questions and answers
Compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality.
- FDA — ingredients suitable for sterile compounding
Reports NAD+ injectable adverse events and ingredient-quality concerns.
- Grant et al. (2019) — human NAD+ infusion pilot
Small IV metabolism study; does not establish benefits of home injections.